Biosafety and laboratory safety for Bright Peak Therapeutics
Bright Peak Therapeutics is a young biotechnology company based with one of its sites in Allschwil. The company develops multifunctional, cytokine-based immunotherapies for the treatment of cancer patients and autoimmune diseases. The core of the development is a unique, cell-free protein synthesis platform for customised, optimised cytokines. We advise Bright Peak Therapeutics on very diverse issues relating to laboratory safety and biosafety since 2020.
Are you looking for an experienced partner? We will be happy to advise you.
The protein synthesis platform and the realisation of associated research work are associated with a wide range of safety issues - in terms of personal protection, biosafety and environmental safety. As biosafety and laboratory safety experts, we have been supporting the young, multinational company for several years with the development and modification of safety measures, risk analyses and any safety-related issues as required.
Our services
- Consultancy on all aspects of biosafety and laboratory safety
- Design and review of safety documents
- Layout review
- Risk analyses
Involved expertise
Biosafety and BiosecurityClient
Bright Peak TherapeuticsIndustry
Industry, Science / researchDiscover similar projects
By expertise
By industry